Pulse Biosciences, Inc. (PLSE)
Company Info
US74587B1017
74587B101
May 18, 2016
Highlights
$1.20B
-$0.99
$832.00K
-$533.00K
-$62.81M
$9.70 - $25.00
$5.00
15.89%
15.16
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Pulse Biosciences, Inc. (PLSE) returned -0.60% year-to-date (YTD) and 43.61% over the past 12 months.
PLSE
-0.60%
1.67%
-19.14%
43.61%
97.98%
13.74%
N/A
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of PLSE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 20.22% | -12.52% | -12.12% | 5.78% | 1.67% | -0.60% | |||||||
| 2024 | -27.45% | 11.26% | -11.84% | -15.38% | 56.72% | -3.12% | 33.69% | 24.60% | -5.90% | -0.63% | 22.78% | -18.64% | 42.24% |
| 2023 | 13.00% | -12.78% | 23.08% | 91.67% | -3.73% | 15.97% | 9.87% | -40.38% | -14.44% | 12.16% | 99.78% | 35.55% | 341.88% |
| 2022 | -17.89% | -58.22% | -4.33% | -48.56% | -10.80% | -31.39% | 1.96% | -18.59% | 81.10% | -8.26% | -5.21% | 38.50% | -81.30% |
| 2021 | 43.13% | -14.35% | -19.04% | -18.67% | -6.33% | -9.09% | 25.00% | 26.34% | -16.60% | -2.36% | -3.75% | -27.04% | -37.93% |
| 2020 | 4.40% | -51.07% | 4.53% | 56.84% | -19.06% | 15.07% | -2.01% | -3.51% | 19.21% | 2.71% | 23.04% | 60.13% | 77.93% |
| 2019 | 16.58% | 33.46% | -1.35% | -8.93% | -25.53% | 10.65% | -1.06% | -8.19% | 28.77% | -8.81% | 3.12% | -7.64% | 17.02% |
| 2018 | -14.07% | -8.78% | -26.86% | 30.01% | -10.23% | -4.12% | -11.76% | 7.49% | -1.18% | -9.73% | -2.11% | -8.61% | -51.44% |
| 2017 | 0.77% | 105.19% | 51.86% | 18.18% | 18.53% | 20.78% | -43.73% | 3.09% | -7.09% | 30.09% | -10.82% | 9.31% | 263.08% |
| 2016 | 2.88% | 4.66% | 1.78% | 7.66% | 27.85% | -2.70% | 0.16% | 6.04% | 55.88% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of PLSE is 68, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Pulse Biosciences, Inc. (PLSE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Pulse Biosciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Pulse Biosciences, Inc. was 97.22%, occurring on Aug 30, 2022. The portfolio has not yet recovered.
The current Pulse Biosciences, Inc. drawdown is 60.91%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.22% | Feb 9, 2021 | 393 | Aug 30, 2022 | — | — | — |
| -86.09% | Jun 20, 2017 | 689 | Mar 16, 2020 | 225 | Feb 4, 2021 | 914 |
| -47.35% | Mar 29, 2017 | 6 | Apr 5, 2017 | 49 | Jun 15, 2017 | 55 |
| -18.97% | Sep 14, 2016 | 63 | Dec 12, 2016 | 13 | Dec 30, 2016 | 76 |
| -10.88% | Feb 24, 2017 | 3 | Feb 28, 2017 | 4 | Mar 6, 2017 | 7 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Pulse Biosciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Pulse Biosciences, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 23.5% positive surprise.
Valuation
The Valuation section provides an overview of how Pulse Biosciences, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for PLSE compared to other companies in the Medical Instruments & Supplies industry. PLSE currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PLSE relative to other companies in the Medical Instruments & Supplies industry. Currently, PLSE has a P/S ratio of 60.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PLSE in comparison with other companies in the Medical Instruments & Supplies industry. Currently, PLSE has a P/B value of 10.1. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |